Provides non-GLP-1 pathways for chronic weight management when eligibility, contraindications, side effects, cost and long-term adherence are considered together.
WEIGHT & METABOLIC HEALTH / PRACTITIONER-GUIDED
Other weight-management medications
EvidenceEvidence in contexti
RegulatoryProduct-specifici

FDA-approved products have human efficacy data for defined chronic weight-management indications; benefits and risks differ substantially by drug.
Prescription or OTC depending on product; indication and formulation specific
WHO MAY BE CONSIDERED
Eligibility starts with your complete health context.
- ✓A chronic weight-management indication is established
- ✓A GLP-1 medicine is not preferred, tolerated or accessible
- ✓Blood pressure, pregnancy potential, mental health, seizure and medication history can be reviewed
WHAT A PRACTITIONER REVIEWS
The information that shapes the decision.
- Weight history, BMI and weight-related conditions
- Blood pressure, heart rate, mood, seizure and glaucoma history
- Pregnancy plans, current medicines and prior treatment response
IMPORTANT SAFETY INFORMATION
Reasons treatment may not be appropriate.
- !Phentermine-containing products can raise heart rate and blood pressure and have controlled-substance considerations.
- !Naltrexone/bupropion is incompatible with opioid use and has seizure, blood-pressure and psychiatric warnings.
- !Orlistat causes GI effects and can affect absorption of fat-soluble vitamins and some medicines.
ORIGINAL SOURCES
Review the evidence behind the option.
YOUR NEXT STEP
Ready for a clinician-led plan?
Clinical review determines the appropriate next step. No treatment is guaranteed.
THE CARE PATH
We order your labs
A licensed clinician reviews results and recommends a plan
Rx sent directly to you when appropriate
Care depends on eligibility and clinical judgment. No prescription is guaranteed. This pathway is not a recommendation for the treatment or test discussed in this guide.
Start your lab reviewExplore free educational tools